How Patient Support Program Providers Adjusted To The Pandemic

Picture of By Daniel Turner, VP Client Services

By Daniel Turner, VP Client Services

March 9, 2022

Physicians feel positive about how Patient Support Programs (PSPs) have evolved in the past two years – especially in terms of responsiveness and the expertise of individuals working on PSPs. The main unmet needs at this time remain the range of service hours and the availability of nurses remotely (either by phone or virtually).

While AbbVie and Janssen tend to be mentioned as better PSPs among the specialties surveyed, more than half of physicians cannot specifically identify a PSP that has been more innovative than others since the beginning of the pandemic. Responsiveness and facilitation of financial support usually explain why a given PSP is preferred over others.

Many specialists believe that biosimilar PSP providers have struggled more than originator drug PSPs since the onset of the pandemic – mainly because of they do not have as many employees and offer a smaller range of services. Please take a look at our infographic based on this study.

Within the specialties surveyed, AbbVie and Janssen are seen as having provided the best overall experience since COVID. In a majority of cases, responsiveness and facilitation of financial support usually explain why a given PSP is preferred over others.

More than half of physicians cannot specifically identify a PSP that has been more innovative than others since the beginning of the pandemic.

Among those that do, AbbVie is more commonly mentioned. AbbVie and Janssen are
particularly likely to be mentioned as having PSPs that have been helpful in supporting with paperwork and reducing administrative burden during the pandemic.

Many specialists believe that biosimilar PSP providers have struggled more than originator drug PSPs since the onset of the pandemic – mainly because of they do not have as many employees and offer a smaller range of services.

  • Which company-sponsored PSPs have performed better overall since the pandemic, and which have been most innovative and supportive?
  • What is the relative performance of biosimilar vs originator brand PSPs?

Infographics may contain select findings from our Independent Studies. Contact us to find out if your organization qualifies for a complimentary presentation with access to the full report.

Past Studies

Which Pharmaceutical Companies are Seen as Leaders?

Impact of Diabetes Apps on Blood Glucose Meter Recommendations

Smart Drugs – Attitudes and public health implications

The Wrong Detailing Approach Could Have Your Reps Facing Closed Doors

CTA

We are here to answer your questions.

Ready to explore how data-driven insights can accelerate your pharmaceutical research? Connect with our team to discuss your goals.